Swedish Orphan Biovitrum (SOBI.ST) Stock Chart - Revenue & Earnings | Quarter Chart

Analyst Forecast

up to date

Select dashboard ▾ New custom dashboard

Income Statement▲

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income

Margin (%)

Gross MarginOperating MarginNet Income Margin

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses

EBITDA

EPS

EPSEPS Diluted

Revenue Variation (%)

Revenue Variation

Income Variation (%)

Gross Profit VariationOperating Income Variation

Revenue YoY Variation (%)

Revenue YoY Variation

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation

Price-to-Earning Ratio

P/E Ratio

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)

Per Share Metrics

Operating IncomeTotal Other Income Expenses NetNet Income

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share

Cash Flow Statement▲

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period

Balance Sheet▲

Current Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities

Quick Ratio

Total AssetsTotal Liabilities

Cash & Equivalents

Total Current AssetsTotal Non Current Assets

Total Assets

Total Current LiabilitiesTotal Non Current Liabilities

Total Liabilities

Total Stockholders Equity

Shareholders Equity

Debt To Equity

Asset Composition

Cash And Cash Equivalents

Debt Structure

Short Term DebtLong Term Debt

Key Metrics▼

Swedish Orphan Biovitrum (SOBI.ST) Stock Chart - Revenue & Earnings | Quarter ChartView Swedish Orphan Biovitrum (SOBI.ST) quarterly revenue, earnings, DCF fair value, and financial charts. Free stock analysis on Quarter Chart.

Swedish Orphan Biovitrum (SOBI.ST) quarterly earnings & revenue

Swedish Orphan Biovitrum (SOBI.ST) reported revenue of 813.61M SEK for Q2 2026, up 27.0% year-over-year, with net income of 113.81M SEK and diluted EPS of 0.33 SEK.

Over the last four reported quarters, Swedish Orphan Biovitrum generated 3.18B SEK in revenue and 143.38M SEK in net income.

Swedish Orphan Biovitrum's next earnings report is scheduled for October 27, 2026; analysts estimate EPS of 0.65 SEK.

Swedish Orphan Biovitrum quarterly results

Fiscal quarter	Revenue	Revenue YoY	Net income	EPS (diluted)
Q2 2026	813.61M SEK	+27.0%	113.81M SEK	0.33 SEK
Q1 2026	745.24M SEK	+11.1%	136.74M SEK	0.39 SEK
Q4 2025	811.43M SEK	+5.2%	193.18M SEK	0.55 SEK
Q3 2025	806.76M SEK	+12.8%	-300.36M SEK	-0.87 SEK
Q2 2025	640.66M SEK	+13.5%	65.98M SEK	0.19 SEK
Q1 2025	670.74M SEK	+3.3%	90.78M SEK	0.26 SEK
Q4 2024	771.49M SEK	+8.6%	144.94M SEK	0.42 SEK
Q3 2024	715.25M SEK	+33.4%	151.89M SEK	0.44 SEK

📈 Analysts estimate SOBI.ST EPS of 0.65 SEK for the upcoming quarter. See Swedish Orphan Biovitrum revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Swedish Orphan Biovitrum (SOBI.ST) — frequently asked questions

When does Swedish Orphan Biovitrum (SOBI.ST) report earnings next?

Swedish Orphan Biovitrum is expected to report earnings on October 27, 2026. Analysts estimate EPS of 0.65 SEK.

What was SOBI.ST's revenue last quarter?

Swedish Orphan Biovitrum reported revenue of 813.61M SEK in Q2 2026, up 27.0% from the same quarter a year earlier.

What was SOBI.ST's EPS last quarter?

Swedish Orphan Biovitrum reported diluted EPS of 0.33 SEK in Q2 2026.

Is Swedish Orphan Biovitrum profitable?

Swedish Orphan Biovitrum is currently profitable, with 143.38M SEK in net income over the last four reported quarters.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK)

Swedish Orphan Biovitrum valuation & key metrics →